At a Glance
Biotech / Therapeutics
11-50
Overview
Aqemia is a next-generation pharmatech company dedicated to transforming the drug discovery process by developing innovative drug candidates for critical diseases, including immuno-oncology. Their unique approach harnesses quantum-inspired physics algorithms and generative AI to create novel therapeutics without relying on traditional experimental data. This advanced methodology accelerates drug design and streamlines the development pipeline, leading to collaborations with major pharmaceutical companies, including a noteworthy $140 million partnership with Sanofi. With a mission to impact patient outcomes, Aqemia's interdisciplinary team comprises professionals from various backgrounds, including machine learning, computational chemistry, and biology, working together to push the boundaries of drug discovery. They are committed to fostering a collaborative and dynamic work environment, centered in Paris, and offer opportunities for professional growth in a rapidly evolving industry.
Actions